The resolution of inflammation: The devil in the flask and in the details

FASEB Journal

Volumn 25, Issue 5, 2011, Pages 1441-1448

  Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anti inflammatory drugs; Eicosanoids; Leukocytes; Omega 3 PUFA; Small molecule therapeutics

Indexed keywords

ACETYLSALICYLIC ACID; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; SALICYLIC ACID;

BIOSYNTHESIS; DRUG SYNTHESIS; ENZYME INHIBITION; HOMEOSTASIS; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL;

EID: 79955663260     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-0502ufm     Document Type: Review

References (76)

1. Friedman, M., and Friedland, G. W. (1998) Medicine's 10 Greatest Discoveries, Yale University Press, New Haven, CT, USA
2. Beveridge, W. I. B. (1950) The Art of Scientific Investigation, Random House, New York
3. Bernard, C. (1957) An Introduction to the Study of Experimental Medicine (Greene, H. C., trans), Dover, New York. Originally published in 1865; first published in English in 1927
4. Serhan, C. N. (2002) Endogenous chemical mediators in antiinflammation and pro-resolution. Curr. Med. Chem. Anti-Inflamm. Anti-Allergy Agents 1, 177-192
5. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug. Discov. 3, 401-416
6. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., and Wallace, J. L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332
7. Flower, R. J. (2006) Prostaglandins, bioassay and inflammation. Br. J. Pharmacol. 147, S182-S192
8. Vane, J. R., and Botting, R. M., eds. (2001) Therapeutic Roles of Selective COX-2 Inhibitors, William Harvey Press, London
9. Vane, J. R. (1982) Adventures and excursions in bioassay: the stepping stones to prostacyclin. In Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures pp. 181-206, Almqvist & Wiksell, Stockholm
10. Taber, C. W. (1970) Taber's Cyclopedic Medical Dictionary, 11th Ed., F. A. Davis, Philadelphia
11. cAli Sina) (1999) The Canon of Medicine (al-Qanun fi'l-tibb) (adapted by Bahktiar, L.), Great Books of the Islamic World, Chicago
12. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204
13. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., and Moussignac, R.-L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037
14. Serhan, C. N., and Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197
15. Robbins, S. L., and Cotran, R. (1979) Pathologic Basis of Disease, 2nd Ed., W. B. Saunders, Philadelphia
16. Majno, G., and Joris, I. (2004) Cells, Tissues, and Disease: Principles of General Pathology, 2nd Ed., Oxford University Press, New York
17. Majno, G., Cotran, R. S., and Kaufman, N., eds. (1982) Current Topics in Inflammation and Infection, Williams & Wilkins, Baltimore
18. Weissmann, G., Smolen, J. E., and Korchak, H. M. (1980) Release of inflammatory mediators from stimulated neutrophils. N. Engl. J. Med. 303, 27-34
19. Savill, J. S., Henson, P. M., and Haslett, C. (1989) Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge- sensitive" recognition mechanism. J. Clin. Invest. 84, 1518-1527
20. Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., and Haslett, C. (1989) Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83, 865-875
21. Haslett, C., and Henson, P. M. (1988) In The Molecular and Cellular Biology of Wound Repair (Clark, R., and Henson, P. M., eds), Plenum Press, New York
22. Cotran, R. S., Kumar, V., Robbins, S. L., and Schoen, F. J. (1994) Robbins Pathologic Basis of Disease, 5th Ed., W. B. Saunders, Philadelphia
23. Samuelsson, B. (1982) From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. In Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures pp. 153-174, Almqvist & Wiksell, Stockholm
24. Von Euler, U. S. (1978) Pieces in the puzzle. In The Excitement and Fascination of Science: Reflections by Eminent Scientists, Vol. 2 (Gibson, W. C., ed) pp. 675-686, Annual Reviews, Palo Alto, CA, USA
25. Houck, J. C., ed. (1979) Chemical Messengers of the Inflammatory Process, Elsevier/North-Holland Biomedical Press, Amsterdam
26. Serhan, C. N. (1994) Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta 1212, 1-25
27. Serhan, C. N., Fiore, S., Brezinski, D. A., and Lynch, S. (1993) Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 32, 6313-6319 (Pubitemid 23208812)
28. Serhan, C. N., Hamberg, M., and Samuelsson, B. (1984) Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc. Natl. Acad. Sci. U. S. A. 81, 5335-5339
29. 4 stable analogues. J. Clin. Invest. 101, 819-826
30. 4 stable analogs are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors. J. Exp. Med. 185, 1693-1704
31. Serhan, C. N., guest ed. (2005) Special issue on lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot. Essent. Fatty Acids 73, 139-321
32. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J. Exp. Med. 183, 137-146
33. Serhan, C. N. (1997) Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins. 53, 107-137
34. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis- infected rats: relationship with concurrent eosinophilia. J. Immunol. 164, 1029-1036
35. Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., and Brady, H. R. (2000) Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte- derived macrophages. J. Immunol. 164, 1663-1667
36. Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., and Serhan, C. N. (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612-619
37. Rossi, A. G., and Sawatzky, D. A., eds. (2008) The Resolution of Inflammation, Birkhäuser Verlag AG, Basel
38. Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., and FitzGerald, G. A. (2001) Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N. Engl. J. Med. 345, 1809-1817
39. FitzGerald, G. A., and Patrono, C. (2001) The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. 345, 433-442
40. Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul- Clark, M. J., and Willoughby, D. A. (1999) Inducible cycloxygenase may have anti-inflammatory properties. Nat. Med. 5, 698-701
41. Serhan, C. N., Chiang, N., and Van Dyke, T. E. (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 249-261
42. Mukherjee, P. K., Marcheselli, V. L., Barreiro, S., Hu, J., Bok, D., and Bazan, N. G. (2007) Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc. Natl. Acad. Sci. U. S. A. 104, 13152-13157
43. Bazan, N. G., Calandria, J. M., and Serhan, C. N. (2010) Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J. Lipid Res. 51, 2018-2031
44. Serhan, C. N. (2007) Resolution phases of inflammation: novel endogenous anti-inflammatory and pro-resolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137
45. Serhan, C. N., and Chiang, N. (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153(Suppl. 1), S200-S215
46. Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., and Serhan, C. N. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291
47. Brooks, D. W. (2009) Resolvyx announced positive data from trial of resolvin RX-10045 for dry eye. [Online] Eye Doc News, http://eyedocnews.com/ 002059-resolvyx-announces-positivedata- from-trial-of-resolvin-rx-10045-for-dry- eye/
48. Clària, J., and Serhan, C. N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cellleukocyte interactions. Proc. Natl. Acad. Sci. U. S. A. 92, 9475-9479
49. Vandivier, R. W., Henson, P. M., and Douglas, I. S. (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129, 1673-1682 (Pubitemid 43895000)
50. Tabas, I. (2010) Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36-46
51. Soehnlein, O., and Lindbom, L. (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10, 427-439
52. 4 receptor. Nat. Med. 8, 1296-1302
53. Maderna, P., Yona, S., Perretti, M., and Godson, C. (2005) Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexinderived peptide Ac(2-26). J. Immunol. 174, 3727-3733
54. Dinarello, C. A. (2010) Anti-inflammatory agents: present and future. Cell 140, 935-950
55. Schroder, K., and Tschopp, J. (2010) The inflammasomes. Cell 140, 821-832
56. Medzhitov, R. (2010) Inflammation 2010: new adventures of an old flame. Cell 140, 771-776
57. Savill, J., and Gregory, C. (2007) Apoptotic PS to phagocyte TIM-4: eat me. Immunity 27, 830-832 (Pubitemid 350251226)
58. Serhan, C. N. (2010) Novel resolution mechanisms in acute inflammation: to resolve or not? Am. J. Pathol. 177, 1576-1591
59. Schmelzer, K., Fahy, E., Subramaniam, S., and Dennis, E. A. (2007) The lipid maps initiative in lipidomics. Methods Enzymol. 432, 247-273
60. Hudert, C. A., Weylandt, K. H., Wang, J., Lu, Y., Hong, S., Dignass, A., Serhan, C. N., and Kang, J. X. (2006) Transgenic mice rich in endogenous n-3 fatty acids are protected from colitis. Proc. Natl. Acad. Sci. U. S. A. 103, 11276-11281
61. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354, 447-455
62. Lands, W. E. M. (2005) Fish, Omega-3 and Human Health, 2nd Ed., AOCS Press, Champaign, IL, USA
63. Simopoulos, A. P., Leaf, A., and Salem, N., Jr. (1999) Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr. 18, 487-489
64. Kasuga, K., Yang, R., Porter, T. F., Agrawal, N., Petasis, N. A., Irimia, D., Toner, M., and Serhan, C. N. (2008) Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181, 8677-8687
65. Damjanov, I. (2010) In memoriam. Guido Majno, M.D., 1922- 2010. Am. J. Pathol. 177, 2150-2151
66. Gronert, K., Maheshwari, N., Khan, N., Hassan, I. R., Dunn, M., and Schwartzman, M. L. (2005) A role for the mouse 12/15- lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267-15278
67. Hassan, I. R., and Gronert, K. (2009) Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 182, 3223-3232
68. Duffield, J. S., Hong, S., Vaidya, V., Lu, Y., Fredman, G., Serhan, C. N., and Bonventre, J. V. (2006) Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177, 5902-5911
69. Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., and Serhan, C. N. (2005) Molecular circuits of resolution: Formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355
70. Morris, T., Stables, M., Colville-Nash, P., Newson, J., Bellingan, G., de Souza, P. M., and Gilroy, D. W. (2010) Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways. Proc. Natl. Acad. Sci. U. S. A. 107, 8842-8847
71. Arita, M., Oh, S., Chonan, T., Hong, S., Elangovan, S., Sun, Y.-P., Uddin, J., Petasis, N. A., and Serhan, C. N. (2006) Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J. Biol. Chem. 281, 22847-22854
72. Serhan, C. N., and Petasis, N. A. (2011) Resolvins and protectins in inflammation-resolution. Chem. Rev.
73. Xu, Z.-Z., Zhang, L., Liu, T., Park, J.-Y., Berta, T., Yang, R., Serhan, C. N., and Ji, R.-R. (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med. 16, 592-597
74. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C.-H., Yang, R., Petasis, N. A., and Serhan, C. N. (2010) Resolvin D1 binds human phagocytes with evidence for pro-resolving receptors. Proc. Natl. Acad. Sci. U. S. A. 107, 1660-1665
75. Liu, Y., Cousin, J. M., Hughes, J., Van Damme, J., Seckl, J. R., Haslett, C., Dransfield, I., Savill, J., and Rossi, A. G. (1999) Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639-3646
76. 4 and annexinderived peptide-stimulated phagocytosis. FASEB J. 24, 4240-4249